We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Says Poor Information Is Main Cause of Approval Delays
U.S. FDA Says Poor Information Is Main Cause of Approval Delays
A U.S. Food and Drug Administration review of drug approvals and denials over a 12-year period shows many delays could be avoided if drugmakers submitted more accurate and useful information.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor